Antibiotic resistance mechanisms of Vibrio cholerae

scientific article published on 20 January 2011

Antibiotic resistance mechanisms of Vibrio cholerae is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1099/JMM.0.023051-0
P698PubMed publication ID21252269
P5875ResearchGate publication ID49771875

P2093author name stringStefan Pukatzki
Daniel Unterweger
Sarah T Miyata
Maya Kitaoka
P2860cites workDNA sequence of both chromosomes of the cholera pathogen Vibrio choleraeQ22122394
P433issuePt 4
P921main subjectVibrio choleraeQ160821
antibiotic resistanceQ380775
P304page(s)397-407
P577publication date2011-01-20
P1433published inJournal of Medical MicrobiologyQ15708716
P1476titleAntibiotic resistance mechanisms of Vibrio cholerae
P478volume60

Reverse relations

cites work (P2860)
Q532408663-Amino 1,8-naphthalimide, a structural analog of the anti-cholera drug virstatin inhibits chemically-biased swimming and swarming motility in vibrios.
Q39839649A genomic island integrated into recA of Vibrio cholerae contains a divergent recA and provides multi-pathway protection from DNA damage
Q52628040ATP-Binding Cassette Transporter VcaM from Vibrio cholerae is Dependent on the Outer Membrane Factor Family for Its Function.
Q40768570An in silico, in vitro and in vivo investigation of indole-3-carboxaldehyde identified from the seawater bacterium Marinomonas sp. as an anti-biofilm agent against Vibrio cholerae O1.
Q30371416Anethole inhibits growth of recently emerged multidrug resistant toxigenic Vibrio cholerae O1 El Tor variant strains in vitro.
Q53685610Anti-biofilm Properties of the Fecal Probiotic Lactobacilli Against Vibrio spp.
Q39617710Antibiotic resistance and plasmid profiling of Vibrio spp. in tropical waters of Peninsular Malaysia
Q38632406Antibiotics resistance in El Tor Vibrio cholerae 01 isolated during cholera outbreaks in Mozambique from 2012 to 2015.
Q57929933Antimicrobial Susceptibility of Environmental Non-O1/Non-O139 Isolates
Q38830043Antimicrobial peptides in marine invertebrate health and disease.
Q60912063Antimicrobial resistance of from sub-Saharan Africa: A systematic review
Q58689795Assessing the Impact of Increasing Antimicrobial Resistance of Vibrio cholerae on the Future Trends of Cholera Epidemic
Q35933945Biochemistry of bacterial multidrug efflux pumps.
Q49472665Bovine Lactoferrin and Lactoferrin-Derived Peptides Inhibit the Growth of Vibrio cholerae and Other Vibrio species
Q92842417Burden of typhoid fever and cholera: similarities and differences. Prevention strategies for European travelers to endemic/epidemic areas
Q92386402Capsaicin inhibitory effects on Vibrio cholerae toxin genes expression
Q30397700Characterization and Genetic Variation of Vibrio cholerae Isolated from Clinical and Environmental Sources in Thailand
Q36969170Cholera outbreak caused by drug resistant Vibrio cholerae serogroup O1 biotype ElTor serotype Ogawa in Nepal; a cross-sectional study
Q35564879Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection
Q30372172Comparative genome analysis of non-toxigenic non-O1 versus toxigenic O1 Vibrio cholerae.
Q39288173Comparative genomics study for identification of drug and vaccine targets in Vibrio cholerae: MurA ligase as a case study
Q54335468Comparison of in vitro antibacterial activities of two cationic peptides CM15 and CM11 against five pathogenic bacteria: Pseudomonas aeruginosa, Staphylococcus aureus, Vibrio cholerae, Acinetobacter baumannii, and Escherichia coli.
Q53460992Computer based screening for novel inhibitors against Vibrio cholerae using NCI diversity set-II: an alternative approach by targeting transcriptional activator ToxT.
Q91971632Confirmed and Potential Roles of Bacterial T6SSs in the Intestinal Ecosystem
Q36290827Conjugated Linoleic Acid Reduces Cholera Toxin Production In Vitro and In Vivo by Inhibiting Vibrio cholerae ToxT Activity.
Q33688967Cyclo(valine-valine) inhibits Vibrio cholerae virulence gene expression.
Q90583429Drug Resistance and the Prevention Strategies in Food Borne Bacteria: An Update Review
Q35847243Drug-resistance mechanisms in Vibrio cholerae O1 outbreak strain, Haiti, 2010.
Q45277848Dynamics analysis of a multi-strain cholera model with an imperfect vaccine.
Q92688758Emergence of Azithromycin Resistance Mediated by Phosphotransferase-Encoding mph(A) in Diarrheagenic Vibrio fluvialis
Q36528810Emergence of Tetracycline Resistant Vibrio cholerae O1 Biotype El Tor Serotype Ogawa with Classical ctxB Gene from a Cholera Outbreak in Odisha, Eastern India
Q38073080Fitness factors in vibrios: a mini-review
Q38419777Gastrointestinal infections in the setting of natural disasters
Q92340042Genomic plasticity associated with antimicrobial resistance in Vibrio cholerae
Q35102858High-throughput screening and whole genome sequencing identifies an antimicrobially active inhibitor of Vibrio cholerae
Q92705298Identification of Widespread Antibiotic Exposure in Patients With Cholera Correlates With Clinically Relevant Microbiota Changes
Q40117738Impact of Awareness Programs on Cholera Dynamics: Two Modeling Approaches
Q48344840Inhibition of the α-carbonic anhydrase from Vibrio cholerae with amides and sulfonamides incorporating imidazole moieties.
Q92296556Mapping cholera outbreaks and antibiotic resistant Vibrio cholerae in India: An assessment of existing data and a scoping review of the literature
Q53340851Modulation of the multidrug efflux pump EmrD-3 from Vibrio cholerae by Allium sativum extract and the bioactive agent allyl sulfide plus synergistic enhancement of antimicrobial susceptibility by A. sativum extract.
Q30428321Molecular analysis of non-O1/non-O139 Vibrio cholerae isolated from hospitalised patients in China
Q34305626Multiple antibiotic resistance of Vibrio cholerae serogroup O139 in China from 1993 to 2009
Q47937884MurB as a target in an alternative approach to tackle the Vibrio cholerae resistance using molecular docking and simulation study
Q36075834Non-O1/Non-O139 Vibrio cholerae Avian Isolate from France Cocarrying the bla(VIM-1) and bla(VIM-4) Genes.
Q90261461Patterns of triclosan resistance in Vibrionaceae
Q64081404Phage Endolysins as Potential Antimicrobials against Multidrug Resistant and : Current Status of Research and Challenges Ahead
Q61856728Phenotypic and genetic characterization of Vibrio cholerae O1 clinical isolates collected through national antimicrobial resistance surveillance network in Nepal
Q42920635Potential for inhibition of bacterial efflux pumps in multidrug-resistant Vibrio cholera
Q36586658RND multidrug efflux pumps: what are they good for?
Q30513891Reassessment of the 2010-2011 Haiti cholera outbreak and rainfall-driven multiseason projections
Q57094470Redefinition and Unification of the SXT/R391 Family of Integrative and Conjugative Elements
Q37345941Reduced Susceptibility to Extended-Spectrum β-Lactams in Vibrio cholerae Isolated in Bangladesh
Q36683682Resistance to Antimicrobial Peptides in Vibrios
Q28821326Selective and Efficient Elimination of Vibrio cholerae with a Chemical Modulator that Targets Glucose Metabolism
Q42200260Structure based virtual screening of novel inhibitors against multidrug resistant superbugs
Q92615774Synthesis, Characterization, Antibacterial Activity, and Computer-Aided Design of Novel Quinazolin-2,4-dione Derivatives as Potential Inhibitors Against Vibrio cholerae
Q30360835The Vibrio cholerae type VI secretion system employs diverse effector modules for intraspecific competition.
Q42716272The time of cholera
Q26745647Therapeutic significance and pharmacological activities of antidiarrheal medicinal plants mention in Ayurveda: A review
Q41921695Vibrio Pathogens: A Public Health Concern in Rural Water Resources in Sub-Saharan Africa
Q37653719Vibrio cholerae O1 with Reduced Susceptibility to Ciprofloxacin and Azithromycin Isolated from a Rural Coastal Area of Bangladesh
Q92037491Virulence, antimicrobial and heavy metal tolerance, and genetic diversity of Vibrio cholerae recovered from commonly consumed freshwater fish
Q30367272Worldwide occurrence of integrative conjugative element encoding multidrug resistance determinants in epidemic Vibrio cholerae O1.
Q40061810Zinc oxide nanoparticles provide anti-cholera activity by disrupting the interaction of cholera toxin with the human GM1 receptor

Search more.